Quantum Coast Capital Founder Matt Cimaglia Discusses 2 Billion Grant for Quantum Industry WWE Saturday Nights Main Event 2026 Highlights Potential for TKO Groups Live Event Strategy US GDP Growth Revised Downward for First Quarter Signals Potential Economic Slowdown SP 500 Holds Gains as Healthcare and Tech Lead Broad Advance Indias GIFT City Emerges as Gateway for Global Stock Investors Morgan Stanley Cuts Home Depot Price Target by 20 What It Means TSM Q1 2026 Earnings Earnings Beat Surprises Market but Stock Slips Slightly BIO Q1 2026 Earnings EPS Falls Short of Estimates Shares Gain IMMR Q3 2025 Earnings EPS Beat Drives Positive Market Reaction Licensing Revenue Remains Opaque CRSR Q1 2026 Earnings Strong EPS Beat Signals Operational Discipline Caseys General Stores CASY Q1 2026 Earnings EPS Surges Past Estimates Yet Shares Edge Lower PureCycle Technologies Q1 2026 Earnings Narrowed Loss Beats Estimates as Stock Surges 84 BlackRock Credit Allocation Income Trust BTZ Inches Higher as YieldDriven Trading Continues TuHURA Biosciences Inc HURA Rises 684 as Price Tests Key Resistance Level CNA Financial CNA Edges Lower Testing Key Support After 166 Decline MESHW Warrants Hold Steady at 030 Consolidation in Tight Range III Surges 392 Information Services Group Tests Resistance Near 474 US Consumer Sentiment Remains Strained Amid Inflation Geopolitical Conflicts and Trade Policy Uncertainty CRAI Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher GATX Corporation Slips 188 as Railcar Leasing Stock Tests Key Support Levels CMDB Q1 2026 Earnings Positive EPS Amid Quiet Market Reaction AEHR Q1 2026 Earnings Narrower Loss Exceeds Expectations as Demand Trends Improve CAE Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises ASPS Q1 2026 Earnings EPS Exceeds Estimates by 349 Shares Surge RadNet Inc RDNT Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares South Bow Corporation SOBO Q1 2026 Earnings EPS Misses Estimates by 37 Amid Challenging Quarter Stock Rises Marginally CRVS Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Pipeline Progress